ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

RARE Ultragenyx Pharmaceutical Inc

41,87
-0,74 (-1,74%)
18 Mai 2024 - Fermé
Retardé de 15 minutes
Quarter End Juin 2022Sept 2022Déc 2022Mar 2023Juin 2023Sept 2023Déc 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Revenu total 89,34M90,7M103,35M100,5M108,31M98,05M127,39M108,83M
Revenu d'exploitation -141,59M-225,07M-145,63M-154,11M-147,96M-145,1M-122,05M-165,35M
Revenu avant impôt -157,86M-238,82M-153,28M-163,48M-159,1M-159M-126,89M-170,23M
Revenu net -158,16M-245,11M-151,83M-163,97M-159,83M-159,65M-123,19M-170,68M
Dividendes privilégiés 00000000
Résultat de base par action 00000000
EBIT -142,23M-226,17M-145,45M-153,8M-149,64M-145,8M-120,01M-166,95M
EBITDA -137,11M-220,37M-140,67M-148,87M-142,6M-137,91M-113,83M-156,5M
Fin d'année 31 Décembre 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Revenu total 133k2,61M51,5M103,71M271,03M351,41M363,33M434,25M
Revenu d'exploitation -248,01M-328,94M-371,37M-424,17M-330,12M-381,74M-648,92M-569,21M
Revenu avant impôt -245,84M-318,34M-197,1M-399,44M-185,36M-452,98M-701,73M-608,46M
Revenu net -245,87M-302,14M-197,61M-402,73M-186,57M-454,03M-707,42M-606,64M
Dividendes privilégiés 00000000
Résultat de base par action -5.962-6.841-3.885-6.963-2.792-6.547-10.078-7.388
EBIT -249,63M-322,41M-206,64M-424,96M-329,51M-383,42M-650,49M-569,55M
EBITDA -244,58M-323,12M-351,84M-415,63M-317,86M-368,51M-630,7M-543,2M

Dernières Valeurs Consultées

Delayed Upgrade Clock